Cardiol Therapeutics Inc (CRDL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 54 | 54 | 56 | 56 | 55 |
| Accounts receivable | 82 | -79 | -22 | 299 | -368 |
| Other Working Capital | 2,793 | 74 | 1,387 | 552 | -828 |
| Other Operating Activity | -7,304 | -9,075 | -5,429 | -7,292 | -4,932 |
| Operating Cash Flow | $-4,375 | $-9,027 | $-4,007 | $-6,386 | $-6,073 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | -15 | 0 | -13 | 0 |
| Investing Cash Flow | $-2 | $-15 | $0 | $-13 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -13 | -13 | -13 | -13 | -13 |
| Common Stock Issued | N/A | N/A | 62,081 | 0 | N/A |
| Other Financing Activity | 0 | 0 | -2,813 | 2,345 | 20,802 |
| Financing Cash Flow | $-13 | $-13 | $59,254 | $2,332 | $20,789 |
| Beginning Cash Position | 74,844 | 83,899 | 28,652 | 32,719 | 18,004 |
| End Cash Position | 70,454 | 74,844 | 83,899 | 28,652 | 32,719 |
| Net Cash Flow | $-4,390 | $-9,055 | $55,247 | $-4,067 | $14,715 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,375 | -9,027 | -4,007 | -6,386 | -6,073 |
| Capital Expenditure | -2 | -15 | N/A | N/A | N/A |
| Free Cash Flow | -4,377 | -9,042 | -4,007 | -6,386 | -6,073 |